Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

8.56
Delayed Data
As of Jun 27
 -0.15 / -1.72%
Today’s Change
1.95
Today|||52-Week Range
9.04
+133.24%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close8.71
Today’s open8.70
Day’s range8.54 - 8.80
Volume1,817,935
Average volume (3 months)3,183,110
Market cap$943.9M
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-73.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.17-0.62%
--Quidel Corp-0.05-0.21%
ALRPRBAlere Inc-0.68-0.17%
VIVOMeridian Bioscience ...-0.15-0.96%
Data as of 06/27/2017

Financials

Next reporting dateAugust 24, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts